Patient Financial News

Subscribe to enjoy similar stories. Pharmaceutical companies are typically rewarded for their innovation with years of market exclusivity before cheaper generics enter the scene. But for diabetes and obesity drugs like Ozempic and Zepbound, known as GLP-1s, cheaper copycats emerged almost immediately.

This troubling incident began when the doctor gave in to her daughter’s request to be involved in the procedure. The patient, a 39-year-old man, had suffered critical head injuries after a tree fell on him, fracturing his skull. Rushed to LKH Hospital in January, he required urgent surgery to save his life. During the operation, the girl drilled a hole in his skull under her mother’s supervision. While the surgery was ultimately successful, the truth of the daughter’s involvement came to light months later in April, triggering public outrage and immediate consequences.

Kusal Mendis hit a patient 74 not out as Sri Lanka beat New Zealand by three wickets under the DLS method with six balls remaining in the rain-hit second ODI. Sri Lanka took an unassailable 2-0 lead in the three-match series with the final game also at Pallekele on Tuesday. Sri Lanka won the first one-day international by 45 runs — also by DLS — after rain disrupted that game at Dambulla. It was Sri Lanka's fifth ODI series win at home in 2024 after it had beaten Zimbabwe, Afghanistan, India and West Indies. Sri Lanka couldn't qualify for next year's Champions Trophy after finishing ninth at last year's 50-over World Cup in India, but has since then lost just one ODI series in Bangladesh while winning five at home. «It is really tough for batters to score runs here,» Sri Lanka captain Charith Asalanka said. «This is just another series. As a team, we are moving towards a big goal and we have to achieve that, this is a process.»

Drugmakers are required to be clearer about explaining risks and side effects.

Indira Gandhi Institute of Child Health in Bengaluru. He called SMA a rare and often devastating genetic disorder while adding this initiative as a transformative one for patients from low-income families. The government has established a Centre of Excellence for Rare Diseases (COERD) at the institute. «We are proud to share that this is the first such centre in the country to enrol 100 beneficiaries under the National policy for the Rare Diseases,» the minister said. Since 2016, the government has been supporting patients with rare diseases and has provided Rs 75 crore as additional fund for the treatment of rare diseases. «We are also investing in infrastructure, training, and outreach to improve early diagnosis, making Karnataka a leader in addressing rare diseases,» Dr Patil said.

Kerala-based naturopath Jacob Vadakkanchery wanted that all medical professionals should specify the side effects in an additional slip in the regional language along with the prescription. The Bench led by Justice BR Gavai said if this practice is followed, then the general practitioners would not be able to attend more than 10-15 patients if this was followed. It was «not practical at all» and for every patient there are different medicines, the apex court said.

Subscribe to enjoy similar stories. Newborn care in India is deeply influenced by a blend of cultural beliefs, traditions, and modern medical science. Although all these customs have been handed down the line of generations and have significant cultural meaning, evidence-based medicine asks for certain practices to be reviewed.

Laurence Balanco of CLSA says Nifty has completed this topping pattern that had formed between August and October – the classic head and shoulders reversal – and that still gives a downside target around 22,800. The midcap sector has also rolled over from the rounding topping pattern that we have had for the past six months and not yet met the minimum downside targets. There is no evidence of slowing in downside momentum and the relative underperformance continues. Be patient and wait for those opportunities to develop. Balanco also says that while we have been down for roughly a quarter, the consolidation can take another quarter. So, this is a process of three to six months which will give us a platform for a resumption of the longer-term uptrend. Let us understand the way the world is getting divided. There is an emerging market basket which is moving lower and then there is a developed market basket which is moving higher. I am mainly talking about the US market here. Do you think there is a sizable disconnect between what the developed markets are doing versus where emerging markets are moving? Could that extend for another quarter or so? Laurence Balanco: It is quite interesting.

Wockhardt on Wednesday reported a net loss of Rs 16 crore in Q2FY25 led by improved performance across UK, India and emerging markets. The Mumbai-based drug maker reported a net loss of Rs 73 crore in Q2FY24.

Subscribe to enjoy similar stories. For 33-year old Pragya Banthia, a London-based Product Operations Manager, the idea of being able to screen for breast cancer at home in a comfortable setting is appealing. “Cancer is a very sensitive topic for me given my family history.

Kalaignar Multi-speciality Hospital in Chennai was stabbed by a man on Wednesday morning at around 10:15 am in the Oncology department, TOI reported on Wednesday. The accused, a 26-year-old man, entered the hospital posing as a patient to meet Dr. Balaji Jaganathan, a medical oncologist. Upon entering the doctor’s room, the man attacked Dr. Jaganathan with a knife, stabbing him in the neck, head, and upper chest. The doctor also sustained injuries to his ear while defending himself. Hospital staff apprehended the attacker as he attempted to flee the scene and is currently in custody at the Guindy police station.

Nawfal's family arrived in Beirut for her wounded daughter's surgery, one of the first things she wanted to do was go to the sea. The Mediterranean had been a constant companion at their home in Gaza before the war. «The moment I smelled the sea, I felt at peace inside — as if I were in Gaza,» she said. But soon their place of refuge reminded her of home in far more distressing ways. Nawfal's 7-year-old daughter, Halima Abou Yassine, is one of a dozen severely wounded Palestinian children brought to Lebanon this year for treatment through a program launched by a British-Palestinian surgeon, Dr. Ghassan Abu Sitta.

The Justice Department is suing to block UnitedHealth Group’s $3.3 billion purchase of Amedisys

Subscribe to enjoy similar stories. Patricia Greene had spent a month recovering from a devastating stroke when her Medicare Advantage insurer, a unit of UnitedHealth Group, decided to stop paying for her nursing home. The 85-year-old was so weak and fragile, her son said, that she couldn’t even get herself out of bed.

Subscribe to enjoy similar stories. The Centre wants states to feed more moong dal to hospital patients, prison inmates and school students, two people aware of the development said. The move is part of an effort to boost moong demand in public institutions in order to stabilize prices for farmers facing low returns due to a supply glut.

Subscribe to enjoy similar stories. More older adults are using marijuana for sleep, anxiety and pain. A small but growing number are taking it to manage their dementia symptoms.

Kidney disease is a global health concern, but conventional tests that check creatinine levels often overlook early signs of damage. To solve this, researchers of Chung-Ang University developed an innovative biosensor that detects symmetric dimethylarginine (SDMA), a byproduct of protein breakdown. The sensor uses special peptides to measure SDMA in urine with high accuracy and does not need additional diagnostic equipment. This simple, cost-effective tool enables early detection of kidney issues, supporting timely interventions and improved patient outcomes.

Subscribe to enjoy similar stories. Mumbai's Nilay Kadam, a 35-year-old businessman, has been going through a stressful time. He had a two-year-old history of psoriasis, which was managed, but a recent increase in personal and professional life issues aggravated his condition and red patches and rashes reappeared on the skin.

cancer patients in Canada seek emergency help before their diagnosis, with more than half being hospitalized following an ER visit, according to new research.A study published in the Canadian Medical Association Journal (CMAJ) on Monday showed that more than a third of cancer patients in Ontario had visited an emergency department in the three months prior to their cancer diagnosis.“This study highlights how frequently patients with cancer are using the emergency department during the diagnostic phase of their cancer journey,” said Dr. Keerat Grewal, study co-author and an emergency medicine physician at Mount Sinai Hospital in Toronto.“It’s almost one in three patients who are using the emergency department prior to their diagnosis and there are certain patient populations who are more likely to use the emergency department,” she told Global News in an interview.The study included more than 650,000 patients who were first diagnosed with cancer between 2014 and 2021 in Ontario.Even though the data was limited to Ontario, Grewal said it’s a trend that’s being seen across Canada.The CMAJ study showed that among the patients with emergency department visits 90 days before a cancer diagnosis, 64 per cent visited an ER once, 23 per cent visited twice and 13 per cent had three or more visits.

Subscribe to enjoy similar stories. Mumbai: Delhi resident Harsha Singh, 31, often visits her family in the city of Mughalsarai, Uttar Pradesh, near Varanasi. That gives her an opportunity to visit Anand Netralaya, a standalone, single-specialty eye hospital.

Subscribe to enjoy similar stories. In terms of recent stock-market frenzies, the Ozempic trade nearly tops the list, second only to speculation that artificial intelligence will soon be writing this column. Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most of those gains flowing to Eli Lilly and Novo Nordisk, the dominant players in the obesity-drug market.